CIGA Healthcare is a British manufacturer of lateral flow assay diagnostic tests. It is under contract to the British government for the supply of AbC-19 rapid antibody tests, a test for the presence of IgG antibody against the SARS-CoV-2 spike protein, as part of the UK Rapid Test Consortium program.
Distribution
CIGA Healthcare will be responsible for assembly and distribution of the AbC-19 rapid antibody tests, and has also been awarded distribution in the US after recent FDA approval.
References
- "Abingdon Health announces its latest expansion and additional manufacturing capacity". Lifescience Industry News. 18 June 2020. Retrieved 12 November 2020.
- "Government invests in UK-developed antibody tests from UK Rapid Test Consortium". GOV.UK. Retrieved 12 November 2020.
- Gill, Dipender; Ponsford, Mark J. (11 November 2020). "Testing for antibodies to SARS-CoV-2". BMJ. 371: m4288. doi:10.1136/bmj.m4288. ISSN 1756-1833. PMID 33315587.
- Symon, Ken (19 October 2020). "Medical diagnostics company signs deal on delivery of Covid-19 tests". businessInsider. Retrieved 12 November 2020.
- "Yorkshire developed Covid-19 test approved for use in North America | TheBusinessDesk.com". Yorkshire. 17 November 2020. Retrieved 13 April 2021.
External links
 | This article about a company of the UK is a stub. You can help Misplaced Pages by expanding it. |
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Misplaced Pages by expanding it. |
 | This article about the COVID-19 pandemic is a stub. You can help Misplaced Pages by expanding it. |